Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Victòria M. Nogués"'
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e16968 (2011)
The increasing rate in antibiotic-resistant bacterial strains has become an imperative health issue. Thus, pharmaceutical industries have focussed their efforts to find new potent, non-toxic compounds to treat bacterial infections. Antimicrobial pept
Externí odkaz:
https://doaj.org/article/cdd725cc3bb941b49085c899cc58295b
Autor:
Victòria M. Nogués, Jose A. Blanco, Guillem Prats-Ejarque, Vivian A. Salazar, Ester Boix, Mohammed Moussaoui
Publikováno v:
Biochimica et biophysica acta. General subjects. 1863(1)
Background Human RNase6 is a small cationic antimicrobial protein that belongs to the vertebrate RNaseA superfamily. All members share a common catalytic mechanism, which involves a conserved catalytic triad, constituted by two histidines and a lysin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d56f2d3a89fdda7d85c4db6717bf818
https://pubmed.ncbi.nlm.nih.gov/30287244
https://pubmed.ncbi.nlm.nih.gov/30287244
Autor:
Daniel Barrientos Sánchez, Marc Torrent, Victòria M. Nogués, Esther Carreras, Mohammed Moussaoui, Ester Boix
Publikováno v:
Biochimie. 93:331-338
The eosinophil cationic protein (ECP) is a human antimicrobial protein involved in the host immune defense that belongs to the pancreatic RNase A family. ECP displays a wide range of antipathogen activities. The protein is highly cationic and its bac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a068b29a540fea221390be655b0945
https://doi.org/10.1016/j.biochi.2010.10.005
https://doi.org/10.1016/j.biochi.2010.10.005
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
PLoS ONE, Vol 6, Iss 2, p e16968 (2011)
PLoS ONE; Vol 6
PLoS ONE
Recercat. Dipósit de la Recerca de Catalunya
instname
Universitat Autònoma de Barcelona
PLoS ONE, Vol 6, Iss 2, p e16968 (2011)
PLoS ONE; Vol 6
PLoS ONE
Recercat. Dipósit de la Recerca de Catalunya
instname
The increasing rate in antibiotic-resistant bacterial strains has become an imperative health issue. Thus, pharmaceutical industries have focussed their efforts to find new potent, non-toxic compounds to treat bacterial infections. Antimicrobial pept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7271a43d2dc8be635c205c149c746119
http://hdl.handle.net/10230/23495
http://hdl.handle.net/10230/23495
Publikováno v:
BMC Bioinformatics, Vol 10, Iss 1, p 373 (2009)
BMC Bioinformatics
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
BMC Bioinformatics
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Background Much effort goes into identifying new antimicrobial compounds able to evade the increasing resistance of microorganisms to antibiotics. One strategy relies on antimicrobial peptides, either derived from fragments released by proteolytic cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::778d87008145fa5109ced670c0adc7d1
http://www.biomedcentral.com/1471-2105/10/373
http://www.biomedcentral.com/1471-2105/10/373
Publikováno v:
Biochemical Journal
Biochemical Journal, Portland Press, 2009, 421 (3), pp.425-434. ⟨10.1042/BJ20082330⟩
Biochemical Journal, Portland Press, 2009, 421 (3), pp.425-434. ⟨10.1042/BJ20082330⟩
ECP (eosinophil cationic protein) is an eosinophil secretion protein with antipathogen activities involved in the host immune defence system. The bactericidal capacity of ECP relies on its action on both the plasma membrane and the bacterial wall. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6e55f9161baac4ec63faa5952ab2b15
https://hal.archives-ouvertes.fr/hal-00479136/document
https://hal.archives-ouvertes.fr/hal-00479136/document
Publikováno v:
Biochemical Journal; Jul2009, Vol. 421 Issue 3, p425-434, 10p